Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07351019 · ClinicalTrials.gov registry record · Phase 4
Colonoscopy Bowel Prep Comparison Among Diabetic Patients
A Phase 4 study of Colon Cancer Screening, sponsored by Eisenhower Army Medical Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT07351019 is a Phase 4 study of Colon Cancer Screening that is actively recruiting participants, run by Eisenhower Army Medical Center. The registered enrollment target is 80 participants, below the 588-participant average among 4 other Colon Cancer Screening trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07351019, a Phase 4 study of Colon Cancer Screening, is actively recruiting participants, sponsored by Eisenhower Army Medical Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if the Golytely or SUPREP bowel preparation works more effectively in bowel cleansing for colorectal cancer screening with colonoscopy in patients with diabetes. The main questions this study aims to answer are: 1. Is there a significant difference in bowel prep cleanse between Golytely and SUPREP in patients with diabetes based on the Boston Bowel Prep Score (BBPS) as assessed by blinded, skilled endoscopists? 2. Is there a significant difference in patients' tolerance between the bowel preparations as assessed by the validated Mayo Bowel Prep Tolerability Form (MBPTF)? Participants will: * Be randomized to take either Golytely or SUPREP bowel preparation prior to their colonoscopy * Complete the MBPTF on the procedure date prior to the scheduled colonoscopy * Undergo a standardized screening colonoscopy during which time a blinded endoscopist will document the participant's BBPS The research team hypothesizes that SUPREP will have a significant difference in tolerability (based on MBPTF), while exhibiting no difference in bowel cleanse (based on BBPS) in the diabetic patient population.
Conditions Studied
Interventions
- DRUG Golytely
- DRUG SUPRPEP
Study Locations (1)
Georgia
- Dwight D. Eisenhower Army Medical Center - Fort Gordon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2026-01-16 |
| Est. Completion | 2026-07-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07351019
The ClinicalTrials.gov registry entry for NCT07351019 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 588-participant average among 4 other Colon Cancer Screening trials with a reported enrollment target (86% lower). The listed sponsor is Eisenhower Army Medical Center, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colon Cancer Screening appearing as the primary indexed condition, and to 2 interventions - of which Golytely is the first listed.
NCT07351019 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT07351019 about?
NCT07351019 is a clinical study titled "Colonoscopy Bowel Prep Comparison Among Diabetic Patients". The goal of this clinical trial is to learn if the Golytely or SUPREP bowel preparation works more effectively in bowel cleansing for colorectal cancer screening with colonoscopy in patients with diabetes. The main questions this study aims to answer are: 1. Is there a significant difference in bow...
What is the current status of trial NCT07351019?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2026-01-16. Estimated completion is 2026-07-28.
What conditions does trial NCT07351019 study?
This clinical trial studies the following conditions: Colon Cancer Screening.
What interventions are being tested in trial NCT07351019?
The interventions under investigation include: Golytely (DRUG), SUPRPEP (DRUG).
Who is sponsoring clinical trial NCT07351019?
This trial is sponsored by Eisenhower Army Medical Center, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07351019 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colon Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Using Social Networks to Encourage Three Peers to Complete Screening for Colorectal Cancer
ACTIVE NOT RECRUITING · NA
-
Johns Hopkins Interactive eGuide to Colonoscopy and Ipad Office Education to Improve Colonoscopy
COMPLETED · NA
-
Patient Reminders Optimizing Mail-in Prevention Testing for Colorectal Cancer
COMPLETED · NA
-
Comparison of Colon Adenoma Detection Rate Using Two Distal Colonoscope Attachments
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.